Frontier Capital Management

Frontier Capital Management is a Boston-based institutional investment management firm founded in 1980. The firm operates as an affiliate of Affiliated Managers Group (AMG) and specializes in growth-oriented equity strategies, particularly in the small-cap and mid-cap spaces. While it is not a biotechnology developer itself, Frontier is a prominent institutional investor within the life sciences sector, frequently appearing as a major shareholder in public biotech, pharmaceutical, and medical technology companies. The firm's investment process relies on a fundamental, bottom-up research approach to identify companies with high growth potential and strong management teams. For a biotech analyst, Frontier represents a significant 'buy-side' entity whose high-conviction positions often track emerging clinical milestones and regulatory trends.